Skip to main content

Join Vox and double your impact

Your support goes further this holiday season. When you buy an annual membership or give a one-time contribution, we’ll give a membership to someone who can’t afford access. It’s a simple way for you to support Vox’s journalism and share it with someone who needs it

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Obamacare’s double-digit rate hike, explained in 400 words

piggy bank
piggy bank

Obamacare premiums are on track to rise faster than ever before in 2017.

The Obama administration released data Monday showing that premiums for midlevel plans will rise, on average, 22 percent between 2016 and 2017.

Yes, that is a huge increase. Last year premiums went up by 7.5 percent.

Premiums are rising on the Obamacare marketplaces largely because the people who signed up for coverage were sicker than the insurance companies expected. This led some health insurers (like Aetna and UnitedHealth) to leave the marketplace. The insurance companies that stayed behind realized they’d have to charge higher premiums in order to cover their members’ medical bills.

What does this mean for Obamacare customers? Most Obamacare enrollees (83 percent) receive subsidies that limit the amount they have to spend on premiums. They only have to spend a certain percent of their income, and then the government will cover the rest.

These people will likely be somewhat insulated from the premium increases. But the premium hike could still be disruptive. These people might have to switch to a new plan if another insurer is offering a lower premium than the one they currently use.

But another 17 percent of Obamacare enrollees don’t receive premium subsidies. And these people are going to be in a really tough spot. They’ll need to decide whether they want to continue spending more to buy their same coverage — or if the insurance doesn’t provide enough value at the higher price.

What does this mean for the future of the law more generally? That’s really hard to tell right now — but there seems to be two plausible interpretations of the data.

One is that this is a one-time course correction. When Obamacare launched, premiums were much lower than analysts had expected. Insurance plans are now bringing their premiums more in line with expectations, and after they do that, they won’t have to make these big rate increases again.

The other is that this is the start of a series of higher rate increases for the health care law — that these new, high premiums might encourage some healthy people (especially those without subsidies) to leave the individual market. Subsides act as a powerful counter-balance to this second scenario, though, by capping enrollees’ contributions.

In either case, these numbers are bad news for Obamacare — we just don’t know how bad, exactly, the news is at this point.

See More:

More in Science

The HighlightThe Highlight
People taking Ozempic are losing muscle mass — and it’s freaking them outPeople taking Ozempic are losing muscle mass — and it’s freaking them out
The HighlightThe Highlight

Yes, there is a downside to GLP-1 drugs — if you aren’t careful.

By Dylan Scott
Future Perfect
Why you should donate blood, briefly explainedWhy you should donate blood, briefly explained
Future Perfect

Giving — it’s in your blood.

By Shayna Korol
Eating the Ocean
The surprisingly profound debate over whether fish feel painThe surprisingly profound debate over whether fish feel pain
Eating the Ocean

We can never prove that other animals are conscious. What do we do with that?

By Marina Bolotnikova
Future Perfect
The US is still a magnet for top foreign students — for nowThe US is still a magnet for top foreign students — for now
Future Perfect

New data shows foreign PhD enrollment remains steady, but the risks to America’s foreign talent pipeline are growing.

By Bryan Walsh
Podcasts
How the brain builds your world of soundHow the brain builds your world of sound
Podcast
Podcasts

The Sound Barrier is a four-episode series where we explore the limits of hearing and the ways we can break through.

By Noam Hassenfeld
Podcasts
Why women are embracing testosteroneWhy women are embracing testosterone
Podcast
Podcasts

Can the hormone be an effective treatment for menopause?

By Miles Bryan and Noel King